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Globalization and Health: The Need for
Global Surveillance
A recent report of A/Sydney/05/97-like
(H3N2) influenza on a cruise ship from New York
to Montreal demonstrates the ease with which
communicable diseases can be transferred across
international borders (1). In this outbreak 2.7% of
passengers and 0.5% of crew had acute febrile
respiratory illness during or after the cruise and
introduced this antigenic variant of influenza A
into both Canada and the United States.
Other viral infections and parasitic diseases
are also associated with population movements.
During 1996, fatal yellow fever infections were
imported into the United States and Switzerland
by tourists who traveled to yellow fever–endemic
areas without yellow fever vaccination (2,3).
During the same year approximately 10,000
cases of malaria were imported into the European
Community, one fourth of them from the United
Kingdom (4). Had mosquito vectors been present,
these diseases could have set up endemic cycles.
Misdiagnosed by an unsuspecting health worker,
they could have been fatal.
Bacterial infections such as meningococcal
meningitis and cholera are also spread with ease
by international travelers. Among the pilgrims
for the Haj in 1987, 7.7 per 100,000 returned to
their countries of origin with meningitis (5).
Cholera, often associated with religious pilgrim-
age and movement of refugees, resulted in 70,000
cases and a 22% fatality rate in 1995 among
recently arrived Rwandese refugees in Goma,
Democratic Republic of the Congo (formerly
Zaire) (6). Rickettsial diseases such as louse-
borne typhus have also recently caused illness
and death among refugee and prison populations
of Burundi and Rwanda (7,8).
Population movement is only part of the
globalization fallout. Expansion in international
travel and commerce in food and medicinal
biologic products provides another potential
source of communicable diseases such as
hepatitis and other bloodborne infections. Social
and environmental changes linked to urbaniza-
tion, mobility, and deforestation have created
new opportunities for infection, while rapid
adaptation of microorganisms has facilitated the
return of old communicable diseases and the
emergence of new ones. With the rapid evolution
of antimicrobial resistance, treatments for a wide
range of parasitic, bacterial, and viral infections
have become less effective. Today, a communi-
cable disease in one country is a global concern.
In industrialized countries, where deaths due
to communicable diseases have greatly decreased
over the past century, the concern is to prevent
diseases from entering and causing an outbreak
or reemergence. In developing countries, the
concern is to detect communicable disease
outbreaks early and to stop their mortality,
spread, and potential harm to trade and tourism.
When cholera entered Peru in 1991, it spread
through the existing sanitation and water
systems, causing more than 3,000 deaths (9).
Seafood export embargoes and decreased tourism
cost an estimated loss of US$770 million to the
Peruvian economy in 1 year. Negative economic
impact can also occur in the more robust
industrialized economies, the most recent example
being bovine spongiform encephalopathy and the
new variant of Creutzfeldt-Jakob disease in the
United Kingdom.
Concerns about communicable diseases in
both industrialized and developing countries can
best be addressed through strong surveillance
systems, renewed commitment to public health,
and strong international partnerships to
strengthen national and international coopera-
tion in communicable disease prevention and
control. In view of the disparity among national
surveillance systems, partnerships in global
surveillance are a logical starting point in this
area of common commitment.
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Global Surveillance: An Essential Public
Health Instrument
With globalization, strengthened communi-
cable disease surveillance at the global level has
become an essential public health instrument. In
addition to providing necessary information for
monitoring communicable diseases and evaluat-
ing control measures, global surveillance serves
as an early warning system for epidemics and
provides the rationale for public health interven-
tion. Early detection of communicable diseases
and immediate public health intervention can
curtail the numbers of communicable illnesses and
deaths and negative effects on international travel
and trade. At the close of the 20th century, which
has seen the affairs of all countries become ever
more intertwined, global communicable disease
surveillance and response is a decisive element in
controlling communicable disease.
Global surveillance provides health advice
for international travelers and guidance to those
involved in international transport and trade,
including the food, plant, animal, and animal
products industries. At the same time, it supplies
crucial data to support the Biological Weapons
Convention and to prevent or anticipate
bioterrorism. To be effective, global surveillance
must be free of, and be perceived as free of,
political bias. Global surveillance requires a
neutral reporting and response environment, and
the World Health Organization (WHO) is
strengthening the framework within which it can
be fostered.
Global Networking
Formal Sources of Information
Government and university centers such as
the U.S. Centers for Disease Control and
Prevention, the U.K. Public Health Laboratory
Service, the French Instituts Pasteur, the global
network of schools of public health, and the
Training in Epidemiology and Public Health
Intervention Network (TEPHINET) provide
confirmed reports of communicable diseases.
Most of these sites are or will become part of the
WHO Collaborating Centre network. This
network, as well as the WHO Regional Offices,
WHO country representatives, and other WHO
and UNAIDS reporting sites, contributes to
global surveillance along with reporting net-
works of other United Nations agencies such as
the United Nations High Commissioner for
Refugees and the United Nations Children’s
Fund. International military networks such as
the U.S. Department of Defense Global Emerging
Infections System, private clinics, individual
scientists, and public health practitioners complete
the network of formal information sources.
Geographic gaps and deficiencies in expertise
in these networks must be rectified. These
networks must develop means of including the
private sector as well as other sources of valid
information such as military and research
laboratories. They must represent both human
and animal infections and provide information
on antimicrobial resistance and the environ-
ment, including water, insect vectors, and
animal reservoirs.
Informal Sources of Information
Telecommunications, media and Internet
access, and rapid information exchange across
the globe permit public health professionals
around the world to communicate more effec-
tively. Many groups, including health profession-
als, nongovernmental organizations, and the
general public, have access to reports on disease
outbreaks, challenging national disease surveil-
lance authorities, which were once the sole source
of such information. Public Internet sites are
dedicated to disease news and include sites for
medicine and biology as well as major news
agencies and wire services.
Such electronic discussion sites, accessible
through free and unrestricted subscription, are
valuable sources of information. Their scope
may be worldwide (ProMed, TravelMed),
regional (PACNET in the Pacific region), or
national (Sentiweb in France). They exemplify
unprecedented potential for increasing public
awareness on public health issues.
The Global Public Health Information
Network is a second generation electronic
surveillance system developed and maintained
by Health Canada. Its powerful search engines
actively crawl the World-Wide Web looking for
reports of communicable diseases and communi-
cable disease syndromes in electronic discussion
groups, news wires, and elsewhere. Searches are
in English and French and will eventually
expand to all official languages of the WHO, to
which it has created close links for verification.
Other network sources for communicable
disease reporting include nongovernmental
organizations such as the Red Cross and Crescent
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societies, Médecins sans Frontières, and Medical
Emergency Relief International (Merlin), and
Christian religious organizations such as the
Catholic and Protestant mission networks.
Legally Mandated Sources of Information
The International Health Regulations (IHR)
are a legal instrument that requires WHO
member states to report diseases of international
importance: currently plague, cholera, and
yellow fever. Countries have not uniformly
complied, often fearing unwarranted reactions
that affect travel and trade. In addition, the
official international reporting mechanism has
not evolved with the new communications
environment and does not include many
communicable diseases of importance to interna-
tional public health. A revision of IHR is therefore
being directed toward a stronger role in global
communicable disease surveillance and control.
Currently being evaluated in a pilot study in 21
countries, the revised IHR emphasizes immedi-
ate notification of all disease outbreaks of urgent
international importance. Electronic reporting of
specific clinical syndromes of importance to
public health will help countries report immedi-
ately, facilitating rapid alert and appropriate
international response while awaiting laboratory
verification. Once the diagnosis is confirmed, it
will also be fed into the system, permitting any
necessary adjustments to the international
response. When the revision is complete, IHR will
constitute an important public health tool as a
source of information linked to an appropriate
international response.
Pulling the Networks Together: Exchange
and Verification of Global Surveillance
Information
A neutral environment, internationally
accepted surveillance standards and norms, and
wider use of modern communication tools is
required to bring all these networks into a global
surveillance system—a true “network of net-
works.” The network has been developed
together with the 191 WHO member states and
other partners, including the European Union-
U.S. Task Force on Emerging Communicable
Diseases and the U.S.-Japan Common Agenda
and has been cited as an area of collaboration by
the G-7/G-8 member countries at both the Lyon
(1996) and the Denver (1997) Summit Meetings.
Requirements for monitoring the intentional
use of pathogenic microbes have also been
addressed in the network, specifically in the
revision of the IHR, in collaboration with the ad
hoc Group of States Parties to the Biological
Weapons Convention.
Nonverified information about communi-
cable diseases coming from within the networks,
including that from IHR, requires rapid
verification from multiple sources other than the
originator. Such “disease intelligence” requires
information management skills, knowledge of
field conditions, and commonly used, standard-
ized medical language compatible with modern
communication technology. WHO has therefore
created an electronic verification system based on
its internationally accepted norms and stan-
dards. This user-friendly system consists of an
electronic repository for ready information
access, regular electronic communication with
network members, and a tracking and follow-up
mechanism to verify each piece of information.
The power of the verification system is its
network of contributors, which includes official
government channels and all participating
networks. Electronic mail provides immediate
follow-up with easy-to-archive responses at low
cost. Communications keep the focus on diseases
with international implications to avoid informa-
tion overload. The criteria used to determine
international implication include suddenness of
onset, illness and death, potential for interna-
tional spread, and likely effects on international
travel and trade. Timely sharing of relevant
information strengthens networking and contrib-
utes to common awareness of current events,
thus increasing international preparedness.
Epidemic Preparedness and Response
Once a communicable disease outbreak has
been confirmed, pertinent information is placed
on the World Wide Web, available to the general
public. At the same time, an international
response including technical and humanitarian
partners is mounted if required. A WHO team
arrives on site within 24 hours of outbreak
confirmation to make an initial assessment and
begin immediate control measures and prepare
the ground for the larger international response
if needed. By linking the international response
to systematic global surveillance, a worldwide
“network of networks” is available from which to
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solicit support, thus ensuring that no one
country, technical, or humanitarian partner
must bear the entire burden.
How It Works in Practice: Global Influenza
Surveillance
Influenza surveillance, one of the most
developed global surveillance and monitoring
systems of WHO, started in 1948 and developed
over the years into a highly successful global
partnership. The network now involves 110
collaborating laboratories in 82 countries,
constantly monitoring locally isolated influenza
viruses and providing information on true
emergence and spread of different strains.
National case detection systems and labora-
tories have been strengthened using internation-
ally accepted norms; virus isolates from national
laboratories are analyzed in more detail in one of
the four WHO Collaborating Centers for
Influenza. The data are then used by experts
associated with the surveillance system to make
recommendations on the three virus strains to be
included in the next season’s influenza vaccine.
Thus, information generated from global surveil-
lance results in an important and unified public
health response each year. The annual design of
the vaccine also represents outstandingly
successful collaboration between the public and
private sectors.
In parallel to the surveillance program,
national and global plans are being developed to
systematically address the next influenza
pandemic. Both the surveillance system and the
elements of the global pandemic plan were tested
during the outbreak of the avian influenza
A(H5N1) virus in humans in Hong Kong in late
1997. The rapid identification of the virus strain
in one of the collaborating laboratories in the
Netherlands, mobilization and coordination of an
investigating team from WHO Collaborating
Centers in the United States, extensive
epidemiologic and laboratory studies, prompt
dissemination of public information, develop-
ment of diagnostic test kits for international
distribution, and identification of a virus line
suitable for vaccine development, all contrib-
uted to a timely, ordered, and effective
response to the outbreak.
WHO will celebrate the 50th anniversary of
global influenza surveillance with a meeting
bringing together participants from the national
influenza laboratories and WHO Collaborating
Centers and other experts. Participants will look
back over past successes and lessons learned and
ahead to needs for improved surveillance and
control of influenza in the 21st century, including
research priorities. The success of the global
influenza program can serve as a model for the
continued development and strengthening of
international collaboration in the surveillance
and control of other communicable diseases.
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